Neuberger Berman Group’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$252K Buy
+4,564
New +$217K ﹤0.01% 1910
2016
Q3
Sell
-286,016
Closed -$5.34M 1626
2016
Q2
$5.34M Sell
286,016
-1,428,900
-83% -$29.8M 0.01% 845
2016
Q1
$46.4M Sell
1,714,916
-26,600
-2% -$763K 0.06% 381
2015
Q4
$52.5M Buy
1,741,516
+246,855
+17% +$7.92M 0.07% 361
2015
Q3
$47.3M Buy
1,494,661
+320,740
+27% +$11.7M 0.06% 384
2015
Q2
$45.7M Buy
1,173,921
+206,524
+21% +$7.12M 0.05% 450
2015
Q1
$34.3M Buy
967,397
+945,002
+4,220% +$30.4M 0.04% 526
2014
Q4
$706K Sell
22,395
-18,900
-46% -$523K ﹤0.01% 1288
2014
Q3
$925K Sell
41,295
-2,150
-5% -$43.1K ﹤0.01% 1263
2014
Q2
$954K Buy
+43,445
New +$826K ﹤0.01% 1263

Other funds holding PAHC

Neuberger Berman Group's PAHC Position: Q1 2026 in Review

Neuberger Berman Group opened a new position in Phibro Animal Health (PAHC) in Q1 2026: 4,564 shares worth $252K. The stake represents ﹤0.01% of the portfolio and ranks #1910 among its holdings. This is a return to the name: Neuberger Berman Group previously reported a position in PAHC as recently as Q2 2016.

Neuberger Berman Group first reported a position in PAHC in Q2 2014 and has held it in 10 quarters since. The position peaked at $52.5M in Q4 2015. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Neuberger Berman Group held 4,564 shares of Phibro Animal Health worth $252K as of Q1 2026.
  • Phibro Animal Health was a new Neuberger Berman Group position in Q1 2026.
  • Phibro Animal Health made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #1910 holding.
  • Neuberger Berman Group first reported a position in Phibro Animal Health in Q2 2014 and has held it in 10 quarters since.
  • Neuberger Berman Group's Phibro Animal Health position peaked at $52.5M in Q4 2015.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.